Augmedix awarded Vizient contract for AI documentation
The contract, effective January 6, 2025, provides Vizient's clients access to Augmedix's full AI suite, including Go, Assist, and Live, integrating with major EHRs.
See the latest news and media coverage for Augmedix. We track all announcements, press releases, and industry mentions in real time, all in one place.
AI-powered ambient medical documentation provider
augmedix.comLast updated
In short: Augmedix was acquired by Commure in a $139 million deal and secured a strategic contract with Vizient to expand its AI documentation suite.
The contract, effective January 6, 2025, provides Vizient's clients access to Augmedix's full AI suite, including Go, Assist, and Live, integrating with major EHRs.
The validation covers its full suite of products for medical notes and data, enhancing efficiency for Oracle customers. It reduces deployment risks and improves clinician workflows.
Augmedix operates as Commure's wholly-owned subsidiary. Stockholders receive $2.35 per share. Augmedix delists from Nasdaq.
Dr. Lamberty reduced charting time by 25%, reclaimed evenings with family, and improved patient care using Augmedix Go's AI documentation.
SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Augmedix (Nasdaq: AUGX), a leader in ambient AI medical documentation and data solutions, today reported financial results...
The company is working with the hospital system to help physicians have an easier time with documenting patient encounters. The firm’s CEO sees potential beyond...
Despite challenges, Augmedix has reported a robust revenue growth of 45.04% over the last twelve months as of Q1 2024, indicating significant top-line expansion. However...
For those considering investing in Augmedix, it's worth mentioning that there are additional InvestingPro Tips available that could provide deeper insights into the company's financial...
Track Augmedix and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Augmedix and other trending companies.